Defining polypharmacy in the elderly: a systematic review protocol

被引:102
|
作者
Mortazavi, Seyede Salehe [1 ]
Shati, Mohsen [2 ]
Keshtkar, Abasali [3 ]
Malakouti, Seyed Kazem [1 ]
Bazargan, Mohsen [4 ]
Assari, Shervin [5 ,6 ]
机构
[1] Iran Univ Med Sci, Sch Behav Sci & Mental Hlth, Tehran Inst Psychiat, Mental Hlth Res Ctr, Tehran, Iran
[2] Univ Social Welf & Rehabil Sci, Dept Aging, Tehran, Iran
[3] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Sci Educ Dev, Tehran, Iran
[4] Charles R Drew Univ Med & Sci, Dept Family Med, 1621 E 120th St, Los Angeles, CA 90059 USA
[5] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
[6] Univ Michigan, Sch Publ Hlth, Ctr Res Ethn Culture & Hlth, Ann Arbor, MI 48109 USA
来源
BMJ OPEN | 2016年 / 6卷 / 03期
关键词
Polypharmacy; elderly; systematic review; definition; Aging; multimorbidity; INAPPROPRIATE MEDICATION USE; BEERS CRITERIA; OLDER-ADULTS; ADHERENCE; PEOPLE; RISK;
D O I
10.1136/bmjopen-2015-010989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Ageingalong with its associated physiological and pathological changesplaces individuals at a higher risk of multimorbidity and treatment-related complications. Today, polypharmacy, a common and important problem related to drug use, occurs subsequent to this multimorbidity in the elderly in all populations. In recent decades, several scientific investigations have studied polypharmacy and its correlates, using different approaches and definitions, and their results have been inconclusive. Differences in definitions and approaches in these studies form a barrier against reaching a conclusion regarding the risk factors and consequences of polypharmacy. It is therefore imperative to establish an appropriate definition of polypharmacy. Methods and analysis A systematic review will be conducted using PubMed, Scopus, Web of Science, EMBASE, PsycINFO and AgeLine bibliographic databases, as well as the grey literature on polypharmacy in older adults to answer these two questions: What definitions in the literature are being used for polypharmacy in older people?, and Which definitions are more comprehensive and applicable? 2 independent reviewers will conduct the primary screening of the articles and data extraction, and eligible sources will be selected after discussing non-conformities. All extracted data from selected articles will be categorised based on the type of study participants, study design and setting, the methodological quality of primary studies and any other potential source of heterogeneity, and results will be summarised in a table, which will contain the levels of evidence and methodological quality of the included studies. The most comprehensive definition of polypharmacy will be selected from the final list of definitions through an international expert webinar. Ethics and Dissemination This research is exempt from ethics approval because the work is carried out on published documents. We will disseminate this protocol in a related peer-reviewed journal.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Reduction of polypharmacy in the elderly - A systematic review of the role of the pharmacist
    Rollason, V
    Vogt, N
    DRUGS & AGING, 2003, 20 (11) : 817 - 832
  • [2] Polypharmacy in multimorbid older adults: protocol for a systematic review
    Sirois, Caroline
    Laroche, Marie-Laure
    Guenette, Line
    Kroger, Edeltraut
    Cooper, Dan
    Emond, Valerie
    SYSTEMATIC REVIEWS, 2017, 6
  • [3] A systematic review on the effectiveness of interventions to reduce polypharmacy in the elderly
    Michelazzo, M. B.
    Milovanovic, S.
    Boccia, S.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 : 351 - 351
  • [4] Polypharmacy in multimorbid older adults: protocol for a systematic review
    Caroline Sirois
    Marie-Laure Laroche
    Line Guénette
    Edeltraut Kröger
    Dan Cooper
    Valérie Émond
    Systematic Reviews, 6
  • [5] Defining clinical credibility: Protocol for a systematic review
    Cardwell, Rachel
    Hillel, Stav Amichai
    Gray, Richard
    Davis, Jenny
    McKenna, Lisa
    COLLEGIAN, 2019, 26 (01) : 222 - 226
  • [6] Defining pediatric polypharmacy: A scoping review
    Bakaki, Paul M.
    Horace, Alexis
    Dawson, Neal
    Winterstein, Almut
    Waldron, Jennifer
    Staley, Jennifer
    Knight, Elia M. Pestana
    Meropol, Sharon B.
    Liu, Rujia
    Johnson, Hannah
    Golchin, Negar
    Feinstein, James A.
    Bolen, Shari D.
    Kleinman, Lawrence C.
    PLOS ONE, 2018, 13 (11):
  • [7] Defining Pediatric Polypharmacy: A Scoping Review
    Bakaki, Paul M.
    Golchin, Negar
    Staley, Jennifer
    Horace, Alexis
    Johnson, Hannah
    Knight, Elia M. Pestana
    Meropol, Sharon B.
    Dawson, Neal V.
    Winterstein, Almut G.
    Kleinman, Lawrence C.
    Bolen, Shari
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 196 - 197
  • [8] Defining loneliness in older adults: protocol for a systematic review
    Bandari, Razieh
    Khankeh, Hamid Reza
    Shahboulaghi, Farahnaz Mohammadi
    Ebadi, Abbas
    Keshtkar, Abbas Ali
    Montazeri, Ali
    SYSTEMATIC REVIEWS, 2019, 8
  • [9] Defining loneliness in older adults: protocol for a systematic review
    Razieh Bandari
    Hamid Reza Khankeh
    Farahnaz Mohammadi Shahboulaghi
    Abbas Ebadi
    Abbas Ali Keshtkar
    Ali Montazeri
    Systematic Reviews, 8
  • [10] Polypharmacy and Malnutrition Management of Elderly Perioperative Patients with Cancer: A Systematic Review
    Kose, Eiji
    Wakabayashi, Hidetaka
    Yasuno, Nobuhiro
    NUTRIENTS, 2021, 13 (06)